Entrepreneurs / Small Business  March 2, 2017

CU Boulder spinoff Muse Biotechnology raises $23M

By

BOULDER — Biotech startup Muse Biotechnology Inc. has raised $23 million in new equity Series B financing.

Kevin Ness

The funding was reported in a Regulation D filing with the U.S. Securities and Exchange Commission, Feb. 28, and was led by Venrock, a venture-capital firm based in Palo Alto, Calif., according to a company press release. Other investors included Foresite Capital and Paladin Capital, as well as Series A investors, NanoDimension and Spruce/MLS.

Muse Bio’s ForgeCraft technology allows for precision editing of the human genome.

Christopher Wood
Christopher Wood is editor and publisher of BizWest, a regional business journal covering Boulder, Broomfield, Larimer and Weld counties. Wood co-founded the Northern Colorado Business Report in 1995 and served as publisher of the Boulder County Business Report until the two publications were merged to form BizWest in 2014. From 1990 to 1995, Wood served as reporter and managing editor of the Denver Business Journal. He is a Marine Corps veteran and a graduate of the University of Colorado Boulder. He has won numerous awards from the Colorado Press Association, Society of Professional Journalists and the Alliance of Area Business Publishers.
Categories: Boulder Entrepreneurs / Small Business Life Sciences Startups Today's News Venture Capital
Sign up for BizWest Daily Alerts
Closing in 8 seconds...